| Project Detail |
LightSense Technologies has developed and patented an innovative, non thermal ablative laser which constitutes a leap forward in laser technology with the potential to dramatically improve laser skincare and position Europe as a leader in medical and aesthetic applications. We are initially focused on tattoo removal because (1) the market is very large and growing, and well defined with clear patient needs, (2) the competitive offering is terrible, and (3) we have already developed meaningful intellectual property in this specific application with approved patents to support our work. We intend to quickly expand beyond tattoo removal, establishing industry-wide and academically-recognized laser solutions for many dermatology applications. We will begin by validating our business plan through the implementation of a Feasibility Study. The study will aim to better understand (A) technology performance in different laser-skin tissue studies, (B) commercial research with key stakeholders, and (C) financial strategy definition, as explained below. With this information, we will improve our laser tattoo removal treatment and refine our go-to- market strategy. LightSense Technologies forecasts ~€30M in revenues by 2021 (~€800M by 2030). Projections take in consideration an average price of € 2,850 per treatment, assuming a decrease thereafter.
|
